Your session is about to expire
← Back to Search
Advance Care Planning for Advance Care Planning
N/A
Waitlist Available
Led By R T Goins, PhD
Research Sponsored by Western Carolina University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cohort 1: baseline, 8 weeks after baseline and 6 months after baseline; cohort 2: baseline, 2nd pretest 6 months after baseline, 8 weeks after 2nd pretest
Awards & highlights
Study Summary
This trial will create a culturally-tailored version of an end-of-life care program, assess its feasibility, and examine if it leads to increased self-efficacy, readiness, and completion of end-of-life care plans.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ cohort 1: baseline, 8 weeks after baseline and 6 months after baseline; cohort 2: baseline, 2nd pretest 6 months after baseline , 8 weeks after 2nd pretest
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cohort 1: baseline, 8 weeks after baseline and 6 months after baseline; cohort 2: baseline, 2nd pretest 6 months after baseline , 8 weeks after 2nd pretest
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Advance Care Planning Engagement Survey Score Change
Change in Self-Report of Advance Directive
Secondary outcome measures
Change in Barriers to Advance Care Planning
Cohort 1: baseline, 8 weeks after baseline and 6 months after baseline; Cohort 2: baseline, 2nd pretest 3 months after baseline , 8 weeks after 2nd pretest
Trial Design
2Treatment groups
Experimental Treatment
Group I: Advance Care Planning WaitlistExperimental Treatment1 Intervention
Waitlist Group- Baseline control measures will be collected at the same time as Cohort 1 completes their pretest. Six Months after Cohort 1, participants will be pretested again before attending a Community Information Session on advance care planning and an one-on-one Sharing Session about Advance Care Planning.
Group II: Advance Care Planning ExperimentalExperimental Treatment1 Intervention
Community Information Session on advance care planning and private one-on-one Sharing Session about advance care planning.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Advance Care Planning
2022
N/A
~200
Find a Location
Who is running the clinical trial?
Western Carolina UniversityLead Sponsor
4 Previous Clinical Trials
124 Total Patients Enrolled
Pacific Institute for Research and EvaluationOTHER
26 Previous Clinical Trials
34,059 Total Patients Enrolled
R T Goins, PhDPrincipal InvestigatorWestern Carolina University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger